- 询价
- Cell Signaling Technology
- 2904
- USA
- 2025年07月15日
- 参见网站
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 宿主：
参见网站
- 库存：
大量
- 供应商：
赛信通（上海）生物试剂有限公司暨美国CST中国分公司
- 抗原来源：
参见网站
- 是否单克隆：
0
- 规格：
150 ul
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Targeting Tumor Vasculature Using VEGF-Toxin Conjugates
, matrix degradation, endothelial cell migration and tube formation. Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF), is an important angiogenic mediator secreted by tumor cells (2 ). VEGF binds to receptor
PriCells: Primary cells culture with supplement of vascular endothelial growth factor (VEGF)
Over-expression of VEGF can cause vascular disease in the retina of the eye and other parts of the body. Drugs such as bevacizumab can inhibit VEGF and control or slow those diseases. VEGF is a sub-family of growth factors, to be specific, the platelet-derived
factor in vivo. Two high-affinity tyrosine kinase receptors for VEGF121 have been identified, VEGFR-1 (FLT -1), and VEGFR-2 (KDR). consistent with the endothelial cell-specific action of VEGF121, expression of both receptor genes
技术资料暂无技术资料 索取技术资料
